Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
InGeneron, Inc. See All Filings	D	2024-03-01 18:08:33 UTC
Amount To Be Raised $1,749,181 Associated Brokers / Dealers N/A CIK Number 0001678766 Filed Document 0001678766-24-000004 Exclusions or Exemptions 506b Accepted Date 2024-03-01 18:08:33 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
InGeneron, Inc. See All Filings	D	2019-04-18 14:48:57 UTC
Amount To Be Raised $23,000,000 Associated Brokers / Dealers N/A CIK Number 0001678766 Filed Document 0001231919-19-000012 Exclusions or Exemptions 506b Accepted Date 2019-04-18 14:48:57 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
InGeneron, Inc. See All Filings	D	2017-03-06 12:16:51 UTC
Amount To Be Raised $19,867,575 Associated Brokers / Dealers N/A CIK Number 0001678766 Filed Document 0001678766-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-03-06 12:16:51 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
InGeneron, Inc. See All Filings	D	2016-12-20 11:42:13 UTC
Amount To Be Raised $2,150,000 Associated Brokers / Dealers N/A CIK Number 0001678766 Filed Document 0001678766-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-12-20 11:42:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Debt
InGeneron, Inc. See All Filings	D	2016-07-07 15:45:51 UTC
Amount To Be Raised $4,500,005 Associated Brokers / Dealers N/A CIK Number 0001678766 Filed Document 0001678766-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-07-07 15:45:51 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity